Molly Davis, NP
Family · Marietta, OHNPI 1124547435
Payments from drug & device makers
Across 566 payments — averaging $15.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- Johnson & Johnson$795
- Ironwood Pharmaceuticals, Inc$569
- Pfizer$481
- Sanofi$450
- plus $3K from 26 others
What the payments were for
- Food & beverage$8,834100%
- Education$350%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 155 | $2,175 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 132 | $1,739 |
| Johnson & Johnson(2 entities) | 54 | $795 |
| Ironwood Pharmaceuticals, Inc | 39 | $569 |
| Pfizer | 23 | $481 |
| Sanofi | 18 | $450 |
| Takeda Pharmaceuticals U.S.A., Inc. | 17 | $444 |
| QOL Medical, LLC | 25 | $426 |
| Daiichi Sankyo Inc. | 15 | $261 |
| Ardelyx, Inc. | 12 | $199 |
| Regeneron Healthcare Solutions, Inc. | 8 | $180 |
| Bristol Myers Squibb | 9 | $145 |
| Nestle Healthcare Nutrition Inc. | 8 | $131 |
| Braintree Laboratories, Inc. | 7 | $130 |
| Redhill Biopharma Inc. | 5 | $96 |
| Aimmune Therapeutics, Inc. | 6 | $96 |
| Amgen | 4 | $73 |
| Evoke Pharma, Inc. | 4 | $61 |
| Intercept Pharmaceuticals, Inc. | 4 | $56 |
| Celltrion USA Inc. | 3 | $46 |
| Seagen Inc. | 2 | $38 |
| Ferring Pharmaceuticals Inc. | 3 | $38 |
| E.r. Squibb & Sons, L.L.C. | 1 | $37 |
| Corcept Therapeutics | 2 | $36 |
| Fresenius Kabi USA, LLC | 2 | $34 |
| Phathom Pharmaceuticals, Inc. | 2 | $32 |
| Edwards Lifesciences | 1 | $18 |
| Boehringer Ingelheim | 1 | $18 |
| Biocon Biologics Inc | 1 | $17 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Novo Nordisk | 1 | $15 |
| Sebela Pharmaceuticals Inc. | 1 | $15 |
How this compares
$8,869 in reported general payments places this provider in the 95th percentile of 6,812 family providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 23 | $98,972 |
| Humira(Cf) PenAdalimumab | 11 | $88,561 |
| LinzessLinaclotide | 51 | $68,587 |
| XifaxanRifaximin | 12 | $47,536 |
| MotegrityPrucalopride Succinate | 28 | $24,389 |
| Dexlansoprazole DrDexlansoprazole | 37 | $9,055 |
| ClenpiqSod Picosulf/Mag Ox/Citric Ac | 23 | $3,971 |
| Mesalamine | 12 | $3,814 |
| Pantoprazole Sodium | 372 | $3,042 |
| Omeprazole | 175 | $2,492 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 40 | $2,422 |
| Sucralfate | 36 | $2,191 |
| Mesalamine DrMesalamine | 11 | $2,034 |
| Lubiprostone | 17 | $1,854 |
| Dicyclomine Hcl | 72 | $1,716 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $2,175 | $167,55974 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $1,739 | $47,53612 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Motegrity | $444 | $24,38928 claims |
| Ferring Pharmaceuticals Inc.Clenpiq | $38 | $3,97123 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,812 family providers in Ohio.
Other family in Marietta
- Eileen FauldsLewis Center$991K
- Leigh Ann PanschDayton$670K
- Natalie BelliniMayfield Heights$582K
- Kaitlyn LovettMontgomery$286K
- Amy RossDayton$281K
- Renee OttSandusky$179K
- Megan MillerSpringfield$156K
- George KnightCincinnati$130K
- Jillian HuntCincinnati$116K
- Florence StewartNew Albany$113K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.